Figure 11 - available via license: Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
Content may be subject to copyright.
1 Roger Heim with a culture of Psilocybe mexicana at the cryptogamy laboratory of the MNHN in Paris, c. 1958. Reproduced with the permission of the MNHN.
Source publication
The first collection of its kind to explore the diverse and global history of psychedelics as they appealed to several generations of researchers and thinkers.
Expanding Mindscapes offers a fascinatingly fluid and diverse history of psychedelics that stretches around the globe. While much of the literature to date has focused on the history of thes...
Context in source publication
Similar publications
This meta-analysis investigates the effect of classic psychedelic drugs on empathy and focuses on cognitive and emotional empathy measured using the Multifaceted Empathy Test (MET). Empathy entails the ability to understand and share the feelings of another and is a significant component of social interaction. Several studies have examined the effe...
Background
Peripheral levels of brain-derived neurotrophic factor (BDNF) are often used as a biomarker for the rapid plasticity-promoting effects of ketamine, psychedelics, and other psychoplastogens in humans. However, studies analyzing peripheral BDNF after psychoplastogen exposure show mixed results. In this meta-analysis, we aimed to test wheth...
Objective:
This study aims to provide an overview of pharmacological trials that examine the neurocognitive effects of psychedelics among healthy individuals and patients with post-traumatic stress disorder (PTSD) or major depressive disorder (MDD).
Methods:
The Preferred Reporting Items for Systematic Reviews (PRISMA) was used as a guide to str...
Introduction: With the progressive advancement of clinical and experimental trials aimed at investigating the pharmacotherapeutic potential of psychedelic substances, there is also the development of other conceptions of use, not only for the treatment of psychiatric disorders, but also for the improvement of emotional/cognitive functions. Objectiv...
![Weekly topics and goals of MCP sessions [21]](publication/378150291/figure/tbl1/AS:11431281223379877@1707757557498/Weekly-topics-and-goals-of-MCP-sessions-21_Q320.jpg)
Background
An advanced cancer diagnosis can be associated with a significant profile of distress. Psychedelic compounds have shown clinically significant effects in the treatment of psychological distress in patients with advanced-stage cancer. Given the challenges of delivering timely and effective intervention in the advanced cancer context, it i...
